Peter Doherty Institute for Infection and Immunity

Peter Doherty Institute for Infection and Immunity
Name	Peter Doherty Institute for Infection and Immunity
Established	2014
Location	Melbourne, Victoria, Australia
Affiliation	University of Melbourne; Royal Melbourne Hospital
Type	Research institute
Director	Brendan Crabb

Peter Doherty Institute for Infection and Immunity is an Australian biomedical research institute established in 2014 and hosted in Melbourne, Victoria, Australia, as a joint venture between the University of Melbourne and the Royal Melbourne Hospital. The institute is named after Nobel Laureate Peter C. Doherty and focuses on translational research in infectious diseases, immunology, and public health, building links with national bodies such as the Commonwealth Scientific and Industrial Research Organisation and international partners like the World Health Organization and the Coalition for Epidemic Preparedness Innovations. Its activities intersect with clinical services at major hospitals, governmental responses to outbreaks including the COVID-19 pandemic, and collaborations with research hubs such as the Walter and Eliza Hall Institute of Medical Research and the Murdoch Children's Research Institute.

History

The institute was created amid policy and institutional developments involving the University of Melbourne, the Royal Melbourne Hospital, the Victorian Government, and federal agencies, following decades of Australian engagement with global initiatives like the Global Fund and historical programs including collaborations with the Commonwealth Serum Laboratories and ties to figures such as Frank Macfarlane Burnet and Howard Florey. Its founding in 2014 built upon precedents set by the Walter and Eliza Hall Institute of Medical Research, the expansion of the Royal Children's Hospital precinct, and post-2000 responses to outbreaks exemplified by the H1N1 influenza pandemic and the Ebola virus epidemic in West Africa. Governance evolved through memoranda with the University of Melbourne and the Royal Melbourne Hospital, while major public health events such as the COVID-19 pandemic accelerated partnerships with entities including the Australian Department of Health and the Victorian Department of Health.

Facilities and Campus

The institute occupies purpose-built facilities within Melbourne’s biomedical precinct adjacent to the Royal Melbourne Hospital, the University of Melbourne Parkville campus, and institutes like the Royal Children's Hospital and the Peter MacCallum Cancer Centre. Laboratories meet biosafety standards compatible with work on viral pathogens, aligning with frameworks developed by the National Health and Medical Research Council and infrastructure programs reminiscent of investments in the Australian Synchrotron and national research campuses. The campus integrates wet labs, clinical microbiology suites, high-containment facilities, and collaborative spaces used by investigators from the Walter and Eliza Hall Institute of Medical Research, the Burnet Institute, and international delegations from the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control.

Research and Programs

Research at the institute spans immunology, vaccinology, pathogen genomics, and infection control, with programs addressing pathogens and conditions that have been central to global health responses including influenza, SARS-CoV-2, tuberculosis, HIV/AIDS, and emerging zoonoses such as Nipah virus and Zika virus. Scientists collaborate with vaccine development partners like CEPI and pharmaceutical groups formerly associated with GlaxoSmithKline and CSL Limited, and engage with consortia including the Global Virome Project and the International Severe Acute Respiratory and Emerging Infection Consortium. Genomics platforms interface with networks such as the Global Initiative on Sharing All Influenza Data and the institute contributes to clinical trials modeled on protocols from WHO and regulatory frameworks used by the Therapeutic Goods Administration and the European Medicines Agency. Collaborative research has linked to landmark studies and researchers associated with recipients of awards like the Nobel Prize in Physiology or Medicine and the Lasker Award.

Clinical Services and Public Health Impact

The institute’s translational focus supports clinical microbiology, infectious disease consultation, and outbreak response capacity for the Royal Melbourne Hospital and wider Victorian health services, working in concert with agencies like the Victorian Department of Health, the Australian Health Protection Principal Committee, and the World Health Organization. During the COVID-19 pandemic, the institute contributed to diagnostic testing scale-up alongside laboratories in the Public Health Laboratory Network and informed policy through collaborations with advisors linked to the Australian Government Department of Health and international public health bodies such as the Pan American Health Organization. The institute’s work influences guidelines from professional societies, including the Infectious Diseases Society of America and national peak bodies connected to the Royal Australasian College of Physicians.

Education and Training

Educational programs link to the University of Melbourne postgraduate offerings, clinical fellowships at the Royal Melbourne Hospital, and training partnerships with institutes such as the Murdoch Children's Research Institute and the Walter and Eliza Hall Institute of Medical Research. The institute hosts doctoral candidates funded through schemes like the National Health and Medical Research Council fellowships and collaborates on workforce development initiatives resembling programs from the World Health Organization and the Bill & Melinda Gates Foundation. Professional development includes workshops and short courses drawing expertise from academics and clinicians affiliated with universities including Harvard University, Oxford University, and Johns Hopkins University.

Governance and Funding

Governance is provided jointly by the University of Melbourne and the Royal Melbourne Hospital, with oversight mechanisms influenced by standards from the National Health and Medical Research Council and reporting aligned with governmental grant processes used by the Australian Research Council and federal departments. Funding sources combine competitive grants from bodies such as the NHMRC, philanthropic support from donors and foundations similar to the Wellcome Trust and the Bill & Melinda Gates Foundation, and partnerships with industry stakeholders including multinational pharmaceutical firms formerly tied to Pfizer and biotechnology collaborators. The institute’s strategic priorities reflect inputs from advisory groups and partnerships with national agencies such as the Department of Health and Aged Care and international collaborators including the World Health Organization.

Category:Medical research institutes in Australia